Reckitt Benckiser Group (RB) Given a GBX 6,800 Price Target at Jefferies Financial Group

Share on StockTwits

Jefferies Financial Group set a GBX 6,800 ($88.85) price target on Reckitt Benckiser Group (LON:RB) in a report released on Wednesday morning. The brokerage currently has a neutral rating on the stock.

A number of other research analysts also recently commented on RB. Credit Suisse Group set a GBX 5,850 ($76.44) price objective on shares of Reckitt Benckiser Group and gave the company a sell rating in a research report on Wednesday, September 19th. JPMorgan Chase & Co. set a GBX 9,000 ($117.60) price objective on shares of Reckitt Benckiser Group and gave the company a buy rating in a research report on Tuesday, September 25th. Morgan Stanley lifted their price objective on shares of Reckitt Benckiser Group from GBX 8,500 ($111.07) to GBX 8,800 ($114.99) and gave the company an overweight rating in a research report on Tuesday, October 2nd. Sanford C. Bernstein set a GBX 8,200 ($107.15) price objective on shares of Reckitt Benckiser Group and gave the company a buy rating in a research report on Thursday, October 4th. Finally, Goldman Sachs Group set a GBX 7,025 ($91.79) price objective on shares of Reckitt Benckiser Group and gave the company a neutral rating in a research report on Monday, October 8th. Three equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and ten have assigned a buy rating to the company. The stock currently has an average rating of Hold and an average target price of GBX 7,065.26 ($92.32).

Shares of RB opened at GBX 5,978 ($78.11) on Wednesday. Reckitt Benckiser Group has a one year low of GBX 5,562 ($72.68) and a one year high of GBX 8,110.43 ($105.98).

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers products for the treatment of analgesic and gastro-intestinal problems, sore throat, cough, pain, and flu, as well as wellness products in sexual wellbeing, footcare, vitamins, and supplements under the Durex, Gaviscon, Nurofen, Mucinex, Scholl/Amopé, and Strepsils brand names.

Featured Article: Terms to Better Understand Call Options

Analyst Recommendations for Reckitt Benckiser Group (LON:RB)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2019 BBNS.